Quick Answer
BridgeBio Oncology Therapeutics, Inc. reported Common Stock Shares Outstanding of 79.99 million shares for the year ending 2025.
- BridgeBio Oncology Therapeutics, Inc. showed an increase of +281,412.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from BridgeBio Oncology Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: 79.99 million shares | Fiscal year 2024: 28,415 shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: